GlassScriptPhysician profile
Matthew Zeiderman
NPI 1700236163
$3,189.98
in general payments reported to CMS, 2019-2025
12 companies · $855 in 2025
The $855 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,244 · 2022: $369 · 2023: $364 · 2024: $358 · 2025: $855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,431 · Travel and Lodging: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,430.57 |
| Travel and Lodging | $147.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequoia Surgical, INC. | $1,200.00 | 2021 | |
| Abbvie INC. | $844.49 | 2023-2025 | Alloderm |
| Integra Lifesciences Corporation | $386.80 | 2022-2023 | Durasorb Monofilament Mesh |
| Musculoskeletal Transplant Foundation INC. | $207.62 | 2023-2025 | |
| Revance Therapeutics, INC. | $158.01 | 2024-2025 | Daxxify |
| Endo Pharmaceuticals INC. | $99.88 | 2023 | Xiaflex |
| Axogen | $87.87 | 2025 | |
| Lifenet Health | $71.17 | 2025 | Theragenesis Wound Matrix |
| Baxter Healthcare | $43.84 | 2021 | |
| Kerecis Limited | $38.67 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Steelhead Surgical INC | $31.11 | 2022 | |
| Motiva USA, LLC | $20.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Zeiderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.